mo:re, a Hamburg, Germany-based life science startup providing a laboratory platform, raised €2.3M in Seed funding.
The round was led by High-Tech Gründerfonds, with participation from Innovationsstarter Fonds Hamburg (IFH), Gilson Inc., NEDGEX, Nidobirds Ventures, and R&R Medical and Martin Blüggel.
The company intends to use the funds to accelerate the commercialization of its platform for complex cell culture workflows.
Led by CEO Lukas Gaats, mo:re provides a laboratory platform that automates the planning, culture, and analysis of complex 3D cell culture models. It also enables verifiable, standardized results without requiring expertise in specific organ systems.
FinSMEs
28/03/2025